Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersE. Joanna Baxter, Anthony R. Green, Linda M. Scott et al.|The Lancet|2005Cited by 3.4k
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Kosuke Yusa, Hiroko Koike-Yusa et al.|Cell Reports|2016Cited by 834
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyJoanne I. Hsu, Margaret A. Goodell, Tajhal Dayaram et al.|Cell stem cell|2018Cited by 423
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformationEsteban A. Orellana, Richard I. Gregory, Qi Liu et al.|Molecular Cell|2021Cited by 359
Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesisSiddhartha Kar, George S. Vassiliou, Pedro M. Quirós et al.|Nature Genetics|2022Cited by 355